DZ3039A1 - Doses mensuelles pour le traitement d'infections par streptococcus pneumoniae. - Google Patents

Doses mensuelles pour le traitement d'infections par streptococcus pneumoniae.

Info

Publication number
DZ3039A1
DZ3039A1 DZ000081A DZ000081A DZ3039A1 DZ 3039 A1 DZ3039 A1 DZ 3039A1 DZ 000081 A DZ000081 A DZ 000081A DZ 000081 A DZ000081 A DZ 000081A DZ 3039 A1 DZ3039 A1 DZ 3039A1
Authority
DZ
Algeria
Prior art keywords
treatment
streptococcus pneumoniae
pneumoniae infections
monthly doses
monthly
Prior art date
Application number
DZ000081A
Other languages
English (en)
Inventor
Thomas Reeves Parr
Magaret Mary Wasilewski
Michael Lee Zeckel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DZ3039A1 publication Critical patent/DZ3039A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DZ000081A 1999-05-03 2000-05-02 Doses mensuelles pour le traitement d'infections par streptococcus pneumoniae. DZ3039A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13225899P 1999-05-03 1999-05-03

Publications (1)

Publication Number Publication Date
DZ3039A1 true DZ3039A1 (fr) 2004-03-27

Family

ID=22453188

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ000081A DZ3039A1 (fr) 1999-05-03 2000-05-02 Doses mensuelles pour le traitement d'infections par streptococcus pneumoniae.

Country Status (29)

Country Link
EP (1) EP1175222B1 (fr)
JP (1) JP2002543146A (fr)
KR (1) KR100757165B1 (fr)
CN (1) CN1349407A (fr)
AR (1) AR023827A1 (fr)
AT (1) ATE284702T1 (fr)
AU (1) AU774647B2 (fr)
BR (1) BR0010244A (fr)
CA (1) CA2372790A1 (fr)
CZ (1) CZ296127B6 (fr)
DE (1) DE60016734T2 (fr)
DZ (1) DZ3039A1 (fr)
EA (1) EA004295B1 (fr)
HK (1) HK1044707B (fr)
HR (1) HRP20010808A2 (fr)
HU (1) HUP0200940A3 (fr)
IL (2) IL145582A0 (fr)
MY (1) MY123542A (fr)
NO (1) NO20015291L (fr)
NZ (1) NZ514467A (fr)
PE (1) PE20010292A1 (fr)
PL (1) PL353444A1 (fr)
SK (1) SK285970B6 (fr)
SV (1) SV2002000065A (fr)
TR (1) TR200103211T2 (fr)
TW (1) TWI255716B (fr)
UA (1) UA73937C2 (fr)
WO (1) WO2000066144A2 (fr)
ZA (1) ZA200108013B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013202360B2 (en) * 2008-08-30 2016-03-24 Melinta Therapeutics, Inc. Methods of treatment using single doses of oritavancin
CN102215858A (zh) * 2008-08-30 2011-10-12 塔尔甘塔治疗公司 使用单剂量奥利万星的治疗方法
US20160206688A1 (en) * 2013-08-26 2016-07-21 The Medicines Company Methods for treating bacteremia and osteomyelitis using oritavancin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
NZ514467A (en) 2005-01-28
CZ20013949A3 (cs) 2002-07-17
TR200103211T2 (tr) 2002-02-21
CA2372790A1 (fr) 2000-11-09
CN1349407A (zh) 2002-05-15
PL353444A1 (en) 2003-11-17
DE60016734D1 (de) 2005-01-20
KR100757165B1 (ko) 2007-09-07
IL145582A (en) 2008-12-29
BR0010244A (pt) 2002-01-08
SK285970B6 (sk) 2007-12-06
WO2000066144A3 (fr) 2001-04-12
HK1044707A1 (en) 2002-11-01
TWI255716B (en) 2006-06-01
NO20015291D0 (no) 2001-10-29
HRP20010808A2 (en) 2002-12-31
EA200101171A1 (ru) 2002-04-25
KR20020008173A (ko) 2002-01-29
AU774647B2 (en) 2004-07-01
IL145582A0 (en) 2002-06-30
ATE284702T1 (de) 2005-01-15
SK15572001A3 (sk) 2003-05-02
HUP0200940A2 (en) 2002-08-28
AR023827A1 (es) 2002-09-04
EP1175222B1 (fr) 2004-12-15
NO20015291L (no) 2001-12-17
SV2002000065A (es) 2002-12-02
HK1044707B (zh) 2005-09-30
EA004295B1 (ru) 2004-02-26
HUP0200940A3 (en) 2002-10-28
WO2000066144A2 (fr) 2000-11-09
EP1175222A2 (fr) 2002-01-30
MY123542A (en) 2006-05-31
DE60016734T2 (de) 2005-12-08
ZA200108013B (en) 2003-03-26
PE20010292A1 (es) 2001-03-07
AU4329200A (en) 2000-11-17
UA73937C2 (en) 2005-10-17
CZ296127B6 (cs) 2006-01-11
JP2002543146A (ja) 2002-12-17

Similar Documents

Publication Publication Date Title
DZ1877A1 (fr) Forme posologiques d'azithromycine pour le traitement d'infection microbiennes.
DZ1876A1 (fr) Médicaments pour administration orale.
MA26822A1 (fr) Composes pour le traitement d'une ischemie.
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
ZA200202306B (en) Topical treatment of streptococcal infections.
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
DE69516524T2 (de) Therapeutisch verwendbare spiro-azabicyclische verbindungen
NL1001950C2 (nl) Verpakken van pleisters.
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
FR2684554B1 (fr) Medicaments pour le traitement d'etats inflammatoires ou pour l'analgesie.
EE9700014A (et) Uus peroraalne ravimvorm, mis sisaldab omeprasooli magneesiumsoola
ITGE930053A1 (it) Dispositivo per la fabbricazione di ovatte.
FR2698268B1 (fr) Composition photoprotectrice administrée par voie orale.
FR2684546B3 (fr) Instrument de traitement, en particulier pour le traitement cosmetique du visage.
DZ3039A1 (fr) Doses mensuelles pour le traitement d'infections par streptococcus pneumoniae.
FR2800614B1 (fr) Composition pour le traitement des infections des voies respiratoires
DZ1988A1 (fr) Thérapie de combinaison pour le traitement de l'hiv.
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
DZ1903A1 (fr) Oligonucléotides pour inhiber le role ders isoprényl protéine transférases.
FI951655A (fi) H.pylori -infektioiden hoito
DE60023722D1 (de) Oligosaccharide die sich vom ribose-ribtol-phosphat herleiten und impfstoffe, die diese oligosaccharide enthalten
IT1289238B1 (it) Composizioni farmaceutiche per il trattamento di infezioni virali comprendenti una 4 arilcumarina
AU4145999A (en) Topical drug for the treatment of viral infections
ITRM920305A0 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.